Axonova is a state-of-the-art laboratory providing services and solutions for
multi-disciplinary fields including the
pharmaceutical, nutraceutical, biomedical and veterinary industries.

The main activities of Axonova are based on two business models. On the one hand,
the company leverages on its platforms with cutting-edge technologies and highly
trained scientists to offer a large portfolio of bio-analysis and research services
ranging from drug discovery to identification and quantification of pathogens as well as
macromolecues in biological samples.

On the other hand, as an innovation-driven company, Axonova has developed its own
pipeline of pharmaceutical drug candidates. As a pioneer drug discovery platform in
Mauritius and inspired from the local biodiversity, the company focuses on research
and innovation to discover new molecules with high therapeutic potential for neurodegenerative disorders.
The assets are then licensed-out to third parties for continuation to the next phases of development.

Latest
developments